透云生物科技集团有限公司（股票代码：01332）于2026年5月4日披露截至2026年4月30日的股份变动月报表。本月该公司注册股本与已发行股本整体保持稳定，未发生新增发行或回购行为。
根据公告显示，透云生物的法定注册股本保持在12,500,000,000股，面值每股0.04港元，合计港币500,000,000元。截至2026年4月30日，已发行股本总数维持为2,805,952,149股，无库存股份。本月未出现新增发行、购回或注销股份的情况，股本结构保持不变。
就股份期权计划而言，期末共有三项购股权计划，合计期权数分别为902,500股、60,200,000股和77,700,000股。第三项购股权计划当月可发行或自库存转让的股份数为25,874,100股。公告显示，透云生物已达到适用的公眾持股量要求，并承诺继续严格遵守相关上市规则及法律法规。
公司月报由董事王亮签署并确认其合规性。截至2026年4月底，透云生物股本总数未发生变动，注册股本和已发行股份数均保持稳定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.